Panacea Life Sciences Holdings, Inc. (PLSH)
OTCMKTS
· Delayed Price · Currency is USD
0.0450
+0.0040 (9.76%)
Mar 9, 2026, 11:26 AM EST
PLSH Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 2.76 | 2.38 | 1.63 | 2.06 | 9.02 | 2.2 |
| Revenue Growth (YoY) | 50.38% | 46.59% | -21.01% | -77.16% | 310.19% | - |
| Cost of Revenue | 6.63 | 6.47 | 6.19 | 6.48 | 11.47 | 3.88 |
| Gross Profit | -3.87 | -4.09 | -4.56 | -4.42 | -2.45 | -1.68 |
| Selling, General & Admin | 1.45 | 1.46 | 1.09 | 1.52 | 2.81 | 0.99 |
| Operating Expenses | 1.45 | 1.46 | 1.09 | 1.52 | 2.81 | 0.99 |
| Operating Income | -5.31 | -5.55 | -5.65 | -5.94 | -5.26 | -2.67 |
| Interest Expense | -1.61 | -1.56 | -2.05 | -1.11 | -1.51 | -0.43 |
| Other Non Operating Income (Expenses) | 0.15 | 0.18 | 0.26 | 0.24 | 0.25 | 0.66 |
| EBT Excluding Unusual Items | -6.76 | -6.92 | -7.44 | -6.81 | -6.52 | -2.45 |
| Gain (Loss) on Sale of Investments | -0.91 | -1.09 | -2.64 | 1.17 | 1.43 | 0.13 |
| Gain (Loss) on Sale of Assets | - | - | - | -0.3 | -0.14 | -0.49 |
| Other Unusual Items | - | 0 | 0.94 | 1.15 | - | - |
| Pretax Income | -7.67 | -8.02 | -9.14 | -4.78 | -5.23 | -2.81 |
| Net Income | -7.67 | -8.02 | -9.14 | -4.78 | -5.23 | -2.81 |
| Net Income to Common | -7.67 | -8.02 | -9.14 | -4.78 | -5.23 | -2.81 |
| Shares Outstanding (Basic) | 17 | 17 | 15 | 18 | 17 | 18 |
| Shares Outstanding (Diluted) | 17 | 17 | 15 | 18 | 17 | 18 |
| Shares Change (YoY) | 18.33% | 11.88% | -16.60% | 5.35% | -4.90% | - |
| EPS (Basic) | -0.45 | -0.48 | -0.62 | -0.27 | -0.31 | -0.16 |
| EPS (Diluted) | -0.45 | -0.48 | -0.62 | -0.27 | -0.31 | -0.16 |
| Free Cash Flow | -1.62 | -1.59 | -2.64 | -4.09 | -10.85 | -10.87 |
| Free Cash Flow Per Share | -0.10 | -0.10 | -0.18 | -0.23 | -0.64 | -0.61 |
| Gross Margin | -139.86% | -171.48% | -280.20% | -214.53% | -27.19% | -76.56% |
| Operating Margin | -192.25% | -232.55% | -347.41% | -288.26% | -58.31% | -121.42% |
| Profit Margin | -277.51% | -336.08% | -561.94% | -232.20% | -58.02% | -127.88% |
| Free Cash Flow Margin | -58.71% | -66.66% | -162.47% | -198.34% | -120.28% | -494.42% |
| EBITDA | -3.64 | -3.83 | -3.92 | -4.2 | -3.57 | -1.87 |
| EBITDA Margin | -131.68% | -160.72% | -241.01% | -203.92% | -39.54% | -85.28% |
| D&A For EBITDA | 1.67 | 1.71 | 1.73 | 1.74 | 1.69 | 0.79 |
| EBIT | -5.31 | -5.55 | -5.65 | -5.94 | -5.26 | -2.67 |
| EBIT Margin | -192.25% | -232.55% | - | -288.26% | -58.31% | -121.42% |
| Advertising Expenses | - | 0.02 | 0.21 | 0.38 | 1.5 | 0.25 |
Source: S&P Capital IQ. Standard template. Financial Sources.